ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression
The purpose of this study was to examine whether the imipridone ONC201/TIC10 affects the metabolic and proliferative activity of medulloblastoma cells in vitro. Preclinical drug testing including extracellular flux analyses (agilent seahorse), MTT assays and Western blot analyses were performed in h...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2b45188c50c34313bc4b235cbf25243c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2b45188c50c34313bc4b235cbf25243c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2b45188c50c34313bc4b235cbf25243c2021-12-01T07:04:49ZONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression2296-634X10.3389/fcell.2021.734699https://doaj.org/article/2b45188c50c34313bc4b235cbf25243c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.734699/fullhttps://doaj.org/toc/2296-634XThe purpose of this study was to examine whether the imipridone ONC201/TIC10 affects the metabolic and proliferative activity of medulloblastoma cells in vitro. Preclinical drug testing including extracellular flux analyses (agilent seahorse), MTT assays and Western blot analyses were performed in high and low c-myc-expressing medulloblastoma cells. Our data show that treatment with the imipridone ONC201/TIC10 leads to a significant inihibitory effect on the cellular viability of different medulloblastoma cells independent of c-myc expression. This effect is enhanced by glucose starvation. While ONC201/TIC10 decreases the oxidative consumption rates in D458 (c-myc high) and DAOY (c-myc low) cells extracellular acidification rates experienced an increase in D458 and a decrease in DAOY cells. Combined treatment with ONC201/TIC10 and the glycolysis inhibitor 2-Deoxyglucose led to a synergistic inhibitory effect on the cellular viability of medulloblastoma cells including spheroid models. In conclusion, our data suggest that ONC201/TIC10 has a profound anti-proliferative activity against medulloblastoma cells independent of c-myc expression. Metabolic targeting of medulloblastoma cells by ONC201/TIC10 can be significantly enhanced by an additional treatment with the glycolysis inhibitor 2-Deoxyglucose. Further investigations are warranted.Annika DwucetMaximilian PrussQiyu CaoMine TanrioverVarun V. PrabhuJoshua E. AllenAurelia PeraudMike-Andrew WesthoffMarkus D. SiegelinChristian Rainer WirtzGeorg Karpel-MasslerFrontiers Media S.A.articlemedulloblastomaONC201/TIC102-DeoxyglucoseseahorsemetabolismBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
medulloblastoma ONC201/TIC10 2-Deoxyglucose seahorse metabolism Biology (General) QH301-705.5 |
spellingShingle |
medulloblastoma ONC201/TIC10 2-Deoxyglucose seahorse metabolism Biology (General) QH301-705.5 Annika Dwucet Maximilian Pruss Qiyu Cao Mine Tanriover Varun V. Prabhu Joshua E. Allen Aurelia Peraud Mike-Andrew Westhoff Markus D. Siegelin Christian Rainer Wirtz Georg Karpel-Massler ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression |
description |
The purpose of this study was to examine whether the imipridone ONC201/TIC10 affects the metabolic and proliferative activity of medulloblastoma cells in vitro. Preclinical drug testing including extracellular flux analyses (agilent seahorse), MTT assays and Western blot analyses were performed in high and low c-myc-expressing medulloblastoma cells. Our data show that treatment with the imipridone ONC201/TIC10 leads to a significant inihibitory effect on the cellular viability of different medulloblastoma cells independent of c-myc expression. This effect is enhanced by glucose starvation. While ONC201/TIC10 decreases the oxidative consumption rates in D458 (c-myc high) and DAOY (c-myc low) cells extracellular acidification rates experienced an increase in D458 and a decrease in DAOY cells. Combined treatment with ONC201/TIC10 and the glycolysis inhibitor 2-Deoxyglucose led to a synergistic inhibitory effect on the cellular viability of medulloblastoma cells including spheroid models. In conclusion, our data suggest that ONC201/TIC10 has a profound anti-proliferative activity against medulloblastoma cells independent of c-myc expression. Metabolic targeting of medulloblastoma cells by ONC201/TIC10 can be significantly enhanced by an additional treatment with the glycolysis inhibitor 2-Deoxyglucose. Further investigations are warranted. |
format |
article |
author |
Annika Dwucet Maximilian Pruss Qiyu Cao Mine Tanriover Varun V. Prabhu Joshua E. Allen Aurelia Peraud Mike-Andrew Westhoff Markus D. Siegelin Christian Rainer Wirtz Georg Karpel-Massler |
author_facet |
Annika Dwucet Maximilian Pruss Qiyu Cao Mine Tanriover Varun V. Prabhu Joshua E. Allen Aurelia Peraud Mike-Andrew Westhoff Markus D. Siegelin Christian Rainer Wirtz Georg Karpel-Massler |
author_sort |
Annika Dwucet |
title |
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression |
title_short |
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression |
title_full |
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression |
title_fullStr |
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression |
title_full_unstemmed |
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression |
title_sort |
onc201/tic10 is empowered by 2-deoxyglucose and causes metabolic reprogramming in medulloblastoma cells in vitro independent of c-myc expression |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/2b45188c50c34313bc4b235cbf25243c |
work_keys_str_mv |
AT annikadwucet onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT maximilianpruss onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT qiyucao onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT minetanriover onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT varunvprabhu onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT joshuaeallen onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT aureliaperaud onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT mikeandrewwesthoff onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT markusdsiegelin onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT christianrainerwirtz onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression AT georgkarpelmassler onc201tic10isempoweredby2deoxyglucoseandcausesmetabolicreprogramminginmedulloblastomacellsinvitroindependentofcmycexpression |
_version_ |
1718405401893928960 |